Monoclonal gammopathy may disturb oestradiol measurement in the treatment and monitoring of in-vitro fertilization

Citation
Kja. Kairemo et al., Monoclonal gammopathy may disturb oestradiol measurement in the treatment and monitoring of in-vitro fertilization, HUM REPR, 14(11), 1999, pp. 2724-2726
Citations number
7
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
HUMAN REPRODUCTION
ISSN journal
02681161 → ACNP
Volume
14
Issue
11
Year of publication
1999
Pages
2724 - 2726
Database
ISI
SICI code
0268-1161(199911)14:11<2724:MGMDOM>2.0.ZU;2-E
Abstract
A 31 year old woman had her treatment for infertility by in-vitro fertiliza tion (IVF) cancelled because a highly elevated serum concentration of oestr adiol was detected, contrary to the clinical picture and that observed by v aginal ultrasound. The immunoassay for measuring oestradiol had been affect ed by circulating heterophilic antibodies in the form of an elevated immuno globulin (Ig) G-kappa M component. This may often be associated with a haem atological malignancy of lymphoid origin, but this patient had a benign mon oclonal gammopathy, Monoclonal gammopathy has not been described in IVF pat ients previously, nor has monoclonal gammopathy been reported as a cause of erroneously elevated oestradiol concentration. This sort of interference i n oestradiol analysis is probably very rare, but may lead to unnecessary ca ncellation of the treatment. A highly elevated oestradiol that is not in ac cordance with the clinical course may indicate heterophilic antibody interf erence, and the cause should always be investigated.